SAN FRANCISCO–Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today confirmed that it had successfully raised an additional $7.1M in financing, led by Gudu Medical, for the company’s Series B round. With this...
LOS ANGELES, CA – MedTech Innovator, the largest accelerator of medical device companies in the world, today announced the 50 companies selected to participate in the organization’s flagship four-month Showcase and Accelerator program, featuring the industry’s most...
SAN FRANCISCO–Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today announced announced enrollment of the first patient in the company’s prospective, multicenter, randomized, double-blind AEROLITH (Acoustic Enhancer...
SAN FRANCISCO–Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today announced that a new U.S. patent titled “Phospholipid compounds and formulations” (patent number 10,953,023) was granted to the company by the United...
SAN FRANCISCO–Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today announced it has received approval of an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to proceed with a pivotal...
Get in touch with us!
Contact us using the form below if you would like more information about our clinical study or if you qualify and would like to participate.